Anti-Chk1 (phospho S345)抗体(ab47318)

发表研究结果有使用 ab47318?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab47318 被引用在 8 文献中.

  • Wang CY  et al. DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress. Oncogene N/A:N/A (2014). PubMed: 24662822
  • Zhou J  et al. A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy. PLoS One 8:e58091 (2013). Human . PubMed: 23483975
  • Ramamoorthy M  et al. RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression. Nucleic Acids Res 40:1621-35 (2012). WB ; Human . PubMed: 22013166
  • Ha K  et al. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage. Mol Cancer Ther 10:1194-206 (2011). WB ; Human . PubMed: 21566061
  • Li Z  et al. An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis. Oncogene : (2010). WB ; Mouse . PubMed: 20154723
  • Merlet J  et al. The CRL2LRR-1 ubiquitin ligase regulates cell cycle progression during C. elegans development. Development 137:3857-66 (2010). IHC-Fr ; Caenorhabditis elegans . PubMed: 20978077
  • Ravi D  et al. A network of conserved damage survival pathways revealed by a genomic RNAi screen. PLoS Genet 5:e1000527 (2009). WB ; Mouse . PubMed: 19543366
  • Martínez-Cruz AB  et al. Spontaneous tumor formation in Trp53-deficient epidermis mediated by chromosomal instability and inflammation. Anticancer Res 29:3035-42 (2009). PubMed: 19661312

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"